Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan
Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan is a drug-linker conjugate for ADC. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan consists of Exatecan and a linker. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan can be used for synthesis of ADCs and for cancer research[1].
Product Specifications
CAS Number
1599439-54-9
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC; Topoisomerase
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mal-peg2-gly-gly-phe-gly-exatecan.html
Purity
98.62
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C57H65FN10O15
Molecular Weight
1149.18
References & Citations
[1]Masuda Takeshi, et al. Preparation of antibody-drug conjugates for cancer therapy. Patent WO2014057687.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Camptothecins
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL
